Skip to content

Efficacy of occlusion therapy initiated in patients with untreated amblyopia beyond 7 years of age

Efficacy of occlusion therapy initiated in patients with untreated amblyopia beyond 7 years of age - Efficacy of occlusion therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON31331
Enrollment
22
Registered
2007-10-31
Start date
2007-11-03
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amblyopia lazy eye

Interventions

Patients receive occlusion therapy (intervention) of the sound eye, three hours per day/ seven days a week for 5 weeks and are instructed to perform near visual activities while patching.

Sponsors

Medisch Centrum Haaglanden, locatie Westeinde
Lead Sponsor

Eligibility

Age
2 Years to 99 Years

Inclusion criteria

Inclusion criteria: All patients between seven and forty years of age, diagnosed with amblyopia associated with strabismus and/ or anisometropia (anisometropia 1.0 D of spherical equivalent or >1.50 D difference in astigmatism in any meridian) will be eligible for the study.

Exclusion criteria

Exclusion criteria: Previous treatment for amblyopia (includes occlusion, or pharmacological defocusing), previous optical correction of the amblyopic eye, ocular cause for reduced visual acuity, diminished acuity due to medication, brain damage, or trauma, neurological disorders, and eye muscle palsies.

Design outcomes

Primary

MeasureTime frame
Primary outcome parameter is visual acuity of the amblyopic eye five weeks after cessation of occlusion therapy.

Secondary

MeasureTime frame
Secondary outcome parameters are cause of amblyopia, age at start occlusion therapy, fixation, visual acuity of the amblyopic eye at start and end of occlusion therapy, anisometropia, and aniseikonia.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)